Hexagon Nutrition Limited (NSE:HEXAGON)
India · Delayed Price · Currency is INR 63.39
-0.59 (-0.92%)
At close: Aug 17, 2026
Hexagon Nutrition Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 4,141 | 3,826 | 3,249 | 2,977 | 2,785 | 2,709 |
Other Revenue | 7.02 | - | - | - | - | - |
| 4,148 | 3,826 | 3,249 | 2,977 | 2,785 | 2,709 | |
Revenue Growth | - | 17.76% | 9.13% | 6.91% | 2.82% | 28.08% |
Cost of Revenue | 2,193 | 1,995 | 1,805 | 1,799 | 1,682 | 1,513 |
Gross Profit | 1,955 | 1,831 | 1,444 | 1,178 | 1,103 | 1,195 |
Selling, General & Admin | 529.52 | 504.38 | 419.07 | 396.91 | 401.35 | 366.22 |
Other Operating Expenses | 875.06 | 800.55 | 616.26 | 536.22 | 476.01 | 466.78 |
Operating Expenses | 1,502 | 1,401 | 1,132 | 1,011 | 970.88 | 886.53 |
Operating Income | 452.26 | 429.58 | 312.23 | 167.76 | 132.57 | 308.92 |
Interest Expense | -42.07 | -40.22 | -27.31 | -28.97 | -21.84 | -12.68 |
Interest & Investment Income | - | - | 4.79 | 7.25 | 4.91 | 3.22 |
Currency Exchange Gain (Loss) | - | - | 21.31 | 29.96 | 12.52 | 24.55 |
Other Non Operating Income (Expenses) | 119.38 | 119.38 | -0.06 | 3.45 | -42.99 | -6.12 |
EBT Excluding Unusual Items | 529.57 | 508.74 | 310.96 | 179.45 | 85.17 | 317.89 |
Gain (Loss) on Sale of Investments | - | - | 25.39 | 15.74 | 9.3 | 6.56 |
Gain (Loss) on Sale of Assets | - | - | 0.81 | -0.17 | -0.23 | 0.12 |
Other Unusual Items | 3.53 | 3.06 | - | - | - | - |
Pretax Income | 533.1 | 511.8 | 337.16 | 195.02 | 94.24 | 324.57 |
Income Tax Expense | 137.55 | 132.43 | 94.11 | 72.13 | 37.15 | 91.41 |
Net Income | 395.55 | 379.37 | 243.05 | 122.89 | 57.09 | 233.16 |
Preferred Dividends & Other Adjustments | - | - | 50 | - | - | - |
Net Income to Common | 395.55 | 379.37 | 193.05 | 122.89 | 57.09 | 233.16 |
Net Income Growth | - | 96.51% | 57.09% | 115.26% | -75.52% | 1.98% |
Shares Outstanding (Basic) | 113 | 111 | 111 | 111 | 111 | 111 |
Shares Outstanding (Diluted) | 123 | 123 | 123 | 123 | 123 | 123 |
Shares Change | 10.43% | -0.12% | - | - | 0.01% | 0.10% |
EPS (Basic) | 3.50 | 3.43 | 1.75 | 1.11 | 0.52 | 2.11 |
EPS (Diluted) | 3.22 | 3.09 | 1.57 | 1.00 | 0.46 | 1.90 |
EPS Growth | - | 96.81% | 57.00% | 117.39% | -75.79% | 2.03% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -11.54 | 282.69 | 83.87 | -64.98 | -51.91 |
Free Cash Flow Per Share | - | -0.09 | 2.30 | 0.68 | -0.53 | -0.42 |
Dividend Per Share | - | - | - | - | - | 0.150 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 47.12% | 47.85% | 44.44% | 39.57% | 39.62% | 44.13% |
Operating Margin | 10.90% | 11.23% | 9.61% | 5.63% | 4.76% | 11.40% |
Profit Margin | 9.54% | 9.92% | 5.94% | 4.13% | 2.05% | 8.61% |
Free Cash Flow Margin | - | -0.30% | 8.70% | 2.82% | -2.33% | -1.92% |
EBITDA | 551.24 | 525.98 | 398.3 | 245.62 | 205.56 | 373.29 |
EBITDA Margin | 13.29% | 13.75% | 12.26% | 8.25% | 7.38% | 13.78% |
D&A For EBITDA | 98.98 | 96.4 | 86.07 | 77.86 | 72.99 | 64.37 |
EBIT | 452.26 | 429.58 | 312.23 | 167.76 | 132.57 | 308.92 |
EBIT Margin | 10.90% | 11.23% | 9.61% | 5.63% | 4.76% | 11.40% |
Effective Tax Rate | 25.80% | 25.87% | 27.91% | 36.99% | 39.42% | 28.16% |
Revenue as Reported | 4,267 | 3,946 | 3,313 | 3,046 | 2,816 | 2,747 |